Tuesday, January 09, 2024 6:07:54 PM
I believe you've got it all wrong. You're right that DCVax-L may be used with the cancers their products are aimed at, but you're wrong about those therapeutics not being needed. If those products improve survival, along with DCVax-L, they will be approved and used. It's very possible they'll replace other products, but the point is they're putting more and better tools in the Drs. tool kits.
In some cancers we're probably curing nearly everyone who have it discovered in a reasonable timeframe, those cancers probably won't get DCVax-L, or any of these new drugs. In so many others, the current benefits are clearly not that good, DCVax-L will help, and so will some of the new drugs you're citing that are under development. Curing cancer is like solving a big puzzle, DCVax's may be one of the pieces, but many other pieces are needed to solve the puzzle.
Remember, for each additional day, week, month or year that a patient lives because of DCVax's, that's also so much longer for them to purchase products from the BP's. The BP's make far more than high priced oncology drugs, your toothpaste is probably made by one of them as well. Of course if their high price oncology drugs work with the DCVax's, they'll sell a lot more of it because the patients living longer, and the treatment is used much longer.
Sure, in time one or more of these BP's may want to purchase the company, we should all be wealthy by the time that happens, if it ever does.
Gary
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM